Literature DB >> 1697567

Co-expression of the genes encoding transforming growth factor-alpha and its receptor in papillary carcinomas of the thyroid.

R Aasland1, L A Akslen, J E Varhaug, J R Lillehaug.   

Abstract

Transforming growth factor-alpha (TGF-alpha) is frequently coexpressed with its receptor, epidermal growth factor receptor (EGF-R), in several types of carcinoma and sarcoma. It is believed that this results in an autocrine stimulation of tumor growth in these tumors. We have found that TGF-alpha and EGF-R/c-erbB RNAs were co-expressed at significantly higher levels in papillary thyroid carcinomas and their lymph-node metastases than in non-neoplastic thyroid tissues. We also observed a low level of expression of RNA specific for insulin-like growth factor I in these tumors, which was highest in a lymph-node metastasis. Autocrine stimulation by TGF-alpha may thus be a common feature of papillary carcinomas of the thyroid. Since EGF is known to induce proliferation and dedifferentiation of normal thyroid cells in culture, TGF-alpha and its receptor may play an important role in thyroid carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697567     DOI: 10.1002/ijc.2910460308

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Analysis of the 2-kilobase latency-associated transcript expressed in PC12 cells productively infected with herpes simplex virus type 1: evidence for a stable, nonlinear structure.

Authors:  E Rødahl; L Haarr
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

2.  Increased binding capacity of receptors for the epidermal growth factor in benign thyroid nodules and thyroid malignancies.

Authors:  B Saller; G Stapfer; B Bein; R Hoermann; F Spelsberg; K Mann
Journal:  Clin Investig       Date:  1993-11

3.  RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR.

Authors:  Michelle Croyle; Nagako Akeno; Jeffrey A Knauf; Doriano Fabbro; Xu Chen; Jacqueline E Baumgartner; Heidi A Lane; James A Fagin
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

4.  Expression of c-erbB-2 protein in papillary thyroid carcinomas.

Authors:  D R Haugen; L A Akslen; J E Varhaug; J R Lillehaug
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

5.  Prognostic impact of EGF-receptor in papillary thyroid carcinoma.

Authors:  L A Akslen; A O Myking; H Salvesen; J E Varhaug
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

6.  Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells.

Authors:  Ichiro Ota; Shigeki Higashiyama; Takashi Masui; Katsunari Yane; Hiroshi Hosoi; Nariaki Matsuura
Journal:  Oncol Rep       Date:  2013-08-06       Impact factor: 3.906

7.  Increased activity of insulin-like growth factor-binding protein in human thyroid papillary cancer tissue.

Authors:  T Yashiro; M Arai; K Shizume; T Obara; H Murakami; N Hizuka; N Emoto; M Miyakawa; K Ito; T Tsushima
Journal:  Jpn J Cancer Res       Date:  1994-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.